Nasdaq Verafin and BioCatch Form Strategic Partnership to Accelerate the Global Fight Against Financial Crime
Nasdaq Verafin (NASDAQ:NDAQ) has formed a strategic partnership with BioCatch to combat financial crime, specifically focusing on payments fraud. The collaboration integrates BioCatch's behavioral and device intelligence with Nasdaq Verafin's fraud detection platform and consortium data network.
The partnership addresses the $486 billion global fraud losses recorded in 2023, leveraging Nasdaq Verafin's network of 2,600+ financial institutions representing over $10 trillion in collective assets. BioCatch's platform analyzes 3,000 unique behavioral and device-related datapoints in real-time to detect fraudulent activities.
The initial phase includes integrating BioCatch alerts into the Nasdaq Verafin platform, enabling real-time fraud prevention and transaction risk evaluation. Future plans include additional product integrations, co-developed solutions, and joint research initiatives.
Nasdaq Verafin (NASDAQ:NDAQ) ha stretto una partnership strategica con BioCatch per combattere i crimini finanziari, con un focus particolare sulle frodi nei pagamenti. La collaborazione integra l'intelligence comportamentale e sui dispositivi di BioCatch con la piattaforma di rilevamento delle frodi e la rete consortile di Nasdaq Verafin.
La partnership interviene sulle perdite globali da frodi, pari a $486 miliardi nel 2023, sfruttando la rete di oltre 2.600 istituti finanziari di Nasdaq Verafin, che rappresentano più di $10 trilioni di attività collettive. La piattaforma di BioCatch analizza in tempo reale 3.000 punti dati unici legati al comportamento e ai dispositivi per individuare attività fraudolente.
La fase iniziale prevede l'integrazione degli avvisi di BioCatch nella piattaforma Nasdaq Verafin, permettendo la prevenzione delle frodi in tempo reale e la valutazione del rischio delle transazioni. I piani futuri includono ulteriori integrazioni di prodotto, soluzioni sviluppate congiuntamente e iniziative di ricerca comuni.
Nasdaq Verafin (NASDAQ:NDAQ) ha establecido una asociación estratégica con BioCatch para combatir el crimen financiero, con un enfoque específico en el fraude en pagos. La colaboración integra la inteligencia comportamental y de dispositivos de BioCatch con la plataforma de detección de fraudes y la red consorcial de Nasdaq Verafin.
La alianza aborda las $486 mil millones en pérdidas por fraude a nivel mundial registradas en 2023, aprovechando la red de más de 2.600 instituciones financieras de Nasdaq Verafin, que representan más de $10 billones en activos colectivos. La plataforma de BioCatch analiza en tiempo real 3.000 puntos de datos únicos relacionados con comportamiento y dispositivos para detectar actividades fraudulentas.
La fase inicial incluye la integración de las alertas de BioCatch en la plataforma de Nasdaq Verafin, habilitando la prevención de fraude en tiempo real y la evaluación del riesgo de transacciones. Los planes futuros contemplan más integraciones de producto, soluciones co-desarrolladas e iniciativas de investigación conjuntas.
Nasdaq Verafin (NASDAQ:NDAQ)은(는) 결제사기 등 금융범죄에 대응하기 위해 BioCatch와 전략적 파트너십을 체결했습니다. 이번 협력은 BioCatch의 행동 및 디바이스 인텔리전스와 Nasdaq Verafin의 사기 탐지 플랫폼 및 컨소시엄 데이터 네트워크를 통합합니다.
이 파트너십은 2023년에 기록된 4,860억 달러 규모의 전 세계 사기 피해에 대응하며, 2,600개 이상의 금융기관과 10조 달러가 넘는 집합 자산을 대표하는 Nasdaq Verafin의 네트워크를 활용합니다. BioCatch의 플랫폼은 사기 활동을 탐지하기 위해 실시간으로 3,000개의 고유한 행동 및 디바이스 관련 데이터 포인트를 분석합니다.
초기 단계에서는 BioCatch 경보를 Nasdaq Verafin 플랫폼에 통합하여 실시간 사기 방지 및 거래 위험 평가를 가능하게 합니다. 향후 추가 제품 통합, 공동 개발 솔루션 및 공동 연구 이니셔티브가 계획되어 있습니다.
Nasdaq Verafin (NASDAQ:NDAQ) a conclu un partenariat stratégique avec BioCatch pour lutter contre la criminalité financière, en se concentrant particulièrement sur la fraude aux paiements. La collaboration intègre l'intelligence comportementale et liée aux appareils de BioCatch à la plateforme de détection des fraudes et au réseau de consortium de Nasdaq Verafin.
Le partenariat répond aux 486 milliards de dollars de pertes mondiales liées à la fraude enregistrées en 2023, en tirant parti du réseau de plus de 2 600 établissements financiers de Nasdaq Verafin, représentant plus de 10 000 milliards de dollars d'actifs collectifs. La plateforme de BioCatch analyse en temps réel 3 000 points de données uniques liés au comportement et aux appareils pour détecter les activités frauduleuses.
La phase initiale comprend l'intégration des alertes BioCatch dans la plateforme Nasdaq Verafin, permettant la prévention de la fraude en temps réel et l'évaluation du risque des transactions. Les plans futurs incluent des intégrations produit supplémentaires, des solutions co-développées et des initiatives de recherche conjointes.
Nasdaq Verafin (NASDAQ:NDAQ) hat eine strategische Partnerschaft mit BioCatch geschlossen, um Finanzkriminalität zu bekämpfen, mit besonderem Schwerpunkt auf Zahlungsbetrug. Die Zusammenarbeit integriert BioCatchs Verhaltens- und Geräteintelligenz in Nasdaq Verafins Betrugserkennungsplattform und Konsortialdaten-Netzwerk.
Die Partnerschaft geht die $486 Milliarden Verluste durch Betrug weltweit im Jahr 2023 an und nutzt Nasdaq Verafins Netzwerk von über 2.600 Finanzinstituten, die mehr als $10 Billionen an kollektiven Vermögenswerten repräsentieren. Die Plattform von BioCatch analysiert in Echtzeit 3.000 eindeutige verhaltens- und gerätebezogene Datenpunkte, um betrügerische Aktivitäten zu erkennen.
In der Anfangsphase werden BioCatch‑Warnungen in die Nasdaq Verafin Plattform integriert, was eine Echtzeit‑Betrugsprävention und Risikobewertung von Transaktionen ermöglicht. Zukünftige Pläne sehen weitere Produktintegrationen, gemeinsam entwickelte Lösungen und gemeinsame Forschungsinitiativen vor.
- Integration combines behavioral intelligence with consortium data for enhanced fraud detection
- Access to data from 2,600+ financial institutions with over $10 trillion in collective assets
- Real-time analysis of 3,000 unique behavioral and device-related datapoints
- Partnership enables pre-emptive action against fraud before funds leave customer accounts
- Current fraud detection systems generating high false positive alerts
- Growing risk of fraud due to accelerating adoption of faster payments
- Financial crime remains a multitrillion-dollar problem globally
Insights
Nasdaq's Verafin-BioCatch partnership combines consortium data with behavioral intelligence to create a stronger fraud prevention ecosystem.
Nasdaq's strategic partnership between its Verafin division and BioCatch represents a significant advancement in the financial crime prevention sector. This collaboration merges two complementary technologies: Verafin's extensive consortium data network (covering 2,600+ financial institutions with $10+ trillion in assets) with BioCatch's behavioral biometrics capabilities (analyzing 3,000 unique behavioral datapoints).
The integration addresses a critical market need as payments fraud accelerates alongside faster payment adoption. According to the release, financial fraud caused estimated global losses of
What makes this partnership particularly valuable is how it transforms the fraud detection approach from reactive to proactive. The integration enables financial institutions to leverage both behavioral and transactional intelligence to potentially stop fraudulent transactions before money leaves accounts. This approach could significantly reduce false positives that plague current systems, which overwhelm investigation teams and create unnecessary friction for legitimate transactions.
For Nasdaq, this partnership strategically enhances its Verafin platform's capabilities, potentially increasing its value proposition to clients and strengthening its competitive position in the financial crime prevention market. The partnership also includes plans for additional product integrations and co-developed solutions, creating multiple avenues for future growth and revenue opportunities in this rapidly evolving sector.
Partnership combines industry-leading consortium data and behavioral intelligence to bolster financial institutions’ defense against fraud
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq Verafin and BioCatch today announced the formation of a strategic partnership to leverage their complementary technology solutions in the fight against payments fraud. The partnership aligns Nasdaq Verafin’s fraud detection platform and consortium data network with BioCatch’s behavioral and device intelligence to more effectively address the rapid growth in payments fraud around the world, one of the financial services industry’s biggest challenges.
Financial crime is a multitrillion-dollar problem with devastating economic and societal impacts worldwide. Payments fraud and scams accounted for the majority of the estimated
The initial phase of the partnership will include the integration of BioCatch alerts and insights into the Nasdaq Verafin platform. This integration will transform fraud prevention efforts, empowering financial institutions to take pre-emptive action against payments fraud, using both behavioral and transactional intelligence to halt fraudulent transactions before the funds leave a customer’s account. By bringing together these two powerful solutions, the partnership equips financial institutions with more holistic risk insights across the lifecycle of a transaction, eliminating signal-delivery silos and enabling teams to both evaluate risk and stop fraudulent transactions in real-time. The partnership will also include additional product integrations and co-developed fraud solutions, as well as joint research and thought leadership.
“As criminal threats grow in scale and sophistication each day, the need for greater industry collaboration has never been more urgent. We are thrilled to partner with BioCatch to further enrich our existing solutions and improve our clients’ ability to fight scams and payments fraud,” said Stephanie Champion, Nasdaq Executive Vice President and Head of Nasdaq Verafin. “This partnership showcases the power of two innovative organizations that have built exceptional, trusted networks. Together, we share a vision to leverage consortium data and behavioral insights as a force multiplier to create a true crime-fighting network that helps financial institutions act faster and better safeguard consumers from harm.”
“The job of a fraud fighter is hard,” BioCatch CEO Gadi Mazor said, “and it’s getting more difficult each day, as our criminal counterparts find new ways to socially engineer and scam bank customers. Our initial integration with Nasdaq Verafin promises to make the job of the fraud fighter immediately easier, giving them single-screen access to powerful, predictive behavioral and transactional fraud signals that enable real-time decisioning across sessions, users, and networks. This partnership underscores the need for a truly global, collaborative approach to fighting financial crime — one that changes the way financial institutions collaborate, protects account-to-account transfers, stops fraudulent payments, and eliminates the money laundering accounts that power financial crime syndicates.”
Nasdaq Verafin's consortium data network is trusted by more than 2,600 financial institutions representing over
BioCatch’s financial crime prevention platform delivers real-time analysis of up to 3,000 unique behavioral and device-related datapoints – keystroke and mouse activity, touch screen behavior, physical device attributes, and more – as people interact with their digital banking platforms. With these inputs, BioCatch’s machine-learning models reveal patterns in user behavior, allowing banks to differentiate between the criminal and the legitimate, and to stop fraud before it happens.
“This partnership represents a win-win by combining the scale of consortium analytics with the precision of behavioral and device intelligence, enabling a comprehensive defense against increasingly sophisticated fraud attacks,” said Julie Conroy, Chief Insights Officer at Datos Insights. “Fraudsters are actively capitalizing on the immediacy of faster payments to commit faster fraud, and it’s imperative that financial organizations have the tools that enable them to move from reactive mode to proactive prevention to protect both their bottom line and consumer trust.”
In the coming weeks, the companies will host a series of webinars to provide more information on the partnership, starting with the first on October 23, 2025. To learn more about the partnership and register for the webinar, please visit https://verafin.com/nasdaq-verafin-biocatch-partnership.
About Nasdaq Verafin
Nasdaq Verafin provides Financial Crime Management Technology solutions for Fraud Detection and Management, AML/CFT Compliance and Management, High-Risk Customer Management, Sanctions Screening and Management, and Information Sharing. More than 2,600 financial institutions, representing over
About BioCatch
BioCatch prevents financial crime by recognizing patterns in human behavior, continuously collecting more than 3,000 anonymized data points – keystroke and mouse activity, touch screen behavior, physical device attributes, and more – as people interact with their digital banking platforms. With these inputs, BioCatch's machine-learning models reveal patterns in user behavior and provide device intelligence that, together, distinguish the criminal from the legitimate. The company’s Customer Innovation Board – an industry-led initiative in partnership with American Express, Barclays, Citi Ventures, HSBC, National Australia Bank, and others – collaborates to pioneer innovative ways of leveraging customer relationships for improved fraud detection. Today, more than 30 of the world's largest 100 banks and 287 total financial institutions deploy BioCatch solutions, analyzing 16 billion user sessions per month and protecting more than 532 million people on more than 1.6 billion devices around the world from fraud and financial crime.
Cautionary Note Regarding Forward-Looking Statements
Information set forth in this release contains forward-looking statements that involve a number of risks and uncertainties. Nasdaq cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information. Forward-looking statements can be identified by words such as “will,” “believe” and other words and terms of similar meaning. Such forward-looking statements include, but are not limited to, statements related to expected results, performance, and synergies. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq’s control. These risks and uncertainties are detailed in Nasdaq’s filings with the U.S. Securities and Exchange Commission, including its annual reports on Form 10-K and quarterly reports on Form 10-Q which are available on Nasdaq’s investor relations website at http://ir.nasdaq.com and the SEC’s website at www.sec.gov. Nasdaq undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
© 2025 Nasdaq, Inc. The Nasdaq logo and the Nasdaq ‘ribbon’ logo are the registered and unregistered trademarks, or service marks, of Nasdaq, Inc. in the U.S. and other countries. All rights reserved. This communication and the content found by following any link herein are being provided to you by Nasdaq, Inc. and/or certain of its subsidiaries (collectively, “Nasdaq”), for informational purposes only. Nasdaq makes no representation or warranty with respect to this communication or such content and expressly disclaims any implied warranty under law. At the time of publication, the information herein was believed to be accurate, however, such information is subject to change without notice. Nothing herein shall constitute a recommendation, solicitation, invitation, inducement, promotion, or offer for the purchase or sale of any investment product, nor shall this material be construed in any way as investment, legal, or tax advice, or as a recommendation, reference, or endorsement by Nasdaq.
Nasdaq Media Relations Contact
David Lurie
+1.914.538.0533
David.Lurie@Nasdaq.com
BioCatch Media Relations Contact
Mac King
+1.206.200.8596
Mac.King@BioCatch.com
-NDAQF-
FAQ
What is the strategic partnership between Nasdaq Verafin and BioCatch in 2025?
How much did global fraud losses amount to in 2023?
How many financial institutions are part of Nasdaq Verafin's consortium network?
What capabilities does BioCatch's financial crime prevention platform offer?
When will Nasdaq Verafin and BioCatch host their first partnership webinar?
